Hypothalamic hamartomas (HH) are rare, non-malignant congenital lesions that disrupt normal hypothalamic function, often leading to premature activation of the hypothalamic-pituitary-gonadal axis and epilepsy. This review examines the underlying pathophysiology, diverse clinical presentations, diagnostic approaches, and emerging management strategies associated with HH, mainly focusing on precocious puberty and epilepsy. The review encompasses the diagnostic and therapeutic approach to these conditions related to HH and discusses other endocrinological and neurological comorbidities to be investigated. The intricate relationship between hormonal dysregulation and neurological disorders underscores the necessity of a multidisciplinary approach to diagnosis and treatment. Furthering our understanding of this complex condition is essential to refine therapeutic protocols and to improve long-term outcomes for affected individuals.
Challenges in hypothalamic hamartoma: focus on practical management / Ventresca, Silvia; Ricciardi, Luca; Petrucci, Simona; Piane, Maria; Bernabucci, Mariangela; Costa, Mattia; Bellone, Giulia; Di Donato, Virginia; De Felice Ciccoli, Cristiana; Mennini, Maurizio; Di Nardo, Giovanni; Orsini, Alessandro; Parisi, Pasquale; Ferretti, Alessandro. - In: MINERVA PEDIATRICS. - ISSN 2724-5780. - (2025).
Challenges in hypothalamic hamartoma: focus on practical management
Silvia VENTRESCA;Luca RICCIARDI;Simona PETRUCCI;Maria PIANE;Mariangela BERNABUCCI;Mattia COSTA;Giulia BELLONE;Virginia DI DONATO;Maurizio MENNINI;Giovanni DI NARDO;Alessandro ORSINI;Pasquale PARISI;Alessandro FERRETTI
2025
Abstract
Hypothalamic hamartomas (HH) are rare, non-malignant congenital lesions that disrupt normal hypothalamic function, often leading to premature activation of the hypothalamic-pituitary-gonadal axis and epilepsy. This review examines the underlying pathophysiology, diverse clinical presentations, diagnostic approaches, and emerging management strategies associated with HH, mainly focusing on precocious puberty and epilepsy. The review encompasses the diagnostic and therapeutic approach to these conditions related to HH and discusses other endocrinological and neurological comorbidities to be investigated. The intricate relationship between hormonal dysregulation and neurological disorders underscores the necessity of a multidisciplinary approach to diagnosis and treatment. Furthering our understanding of this complex condition is essential to refine therapeutic protocols and to improve long-term outcomes for affected individuals.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


